[미국특허]
Drug reconstitution and delivery device and methods
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61M-037/00
A61M-031/00
A61M-005/00
A61M-005/142
A61M-005/19
A61M-005/24
A61M-005/145
출원번호
US-0629184
(2012-09-27)
등록번호
US-9999720
(2018-06-19)
발명자
/ 주소
Uhland, Scott A.
Linn, Felicia
Recht, Michael I.
출원인 / 주소
PALO ALTO RESEARCH CENTER INCORPORATED
대리인 / 주소
Hollingsworth Davis, LLC
인용정보
피인용 횟수 :
0인용 특허 :
47
초록▼
Devices and methods are provided for drug delivery. The device may include a housing having a first compartment containing a drug in a dry, solid form, a second compartment containing a liquid carrier for the drug, and an expansion member located within or adjacent to the first or second compartment
Devices and methods are provided for drug delivery. The device may include a housing having a first compartment containing a drug in a dry, solid form, a second compartment containing a liquid carrier for the drug, and an expansion member located within or adjacent to the first or second compartment. The second compartment may be fluidly connectable to the first compartment by a rupturable barrier or mechanical valve. The device may also include an actuation system configured to expand the expansion member to rupture the rupturable barrier or open the mechanical valve and permit the liquid carrier to flow into the first compartment and mix with the drug to form a reconstituted drug solution.
대표청구항▼
1. A drug delivery device comprising: a housing configuration for implantation in a human or animal subject which comprises: a first compartment containing a drug in a dry, solid form;a second compartment containing a liquid carrier for the drug, the second compartment being fluidly connectable to t
1. A drug delivery device comprising: a housing configuration for implantation in a human or animal subject which comprises: a first compartment containing a drug in a dry, solid form;a second compartment containing a liquid carrier for the drug, the second compartment being fluidly connectable to the first compartment by a rupturable barrier or mechanical valve; andan expansion member located within or adjacent to the first or second compartment, wherein the expansion member is a balloon structure comprising a flexible, elastomeric sheet; andan actuation system configured to expand the expansion member to rupture the rupturable barrier or open the mechanical valve and to expand and contract the expansion member to produce a mixing action to permit the liquid carrier to flow into the first compartment and mix with the drug to form a reconstituted drug solution. 2. The device of claim 1, wherein the device is configured such that continued expansion of the expansion member causes the reconstituted drug solution to be expelled from the device via a release outlet in at least one of the first and second compartments. 3. The device of claim 1, wherein the actuation system is configured to generate a displacement fluid that expands the expansion member. 4. The device of claim 1, wherein the actuation system comprises an electrochemical pump. 5. The device of claim 1, wherein the rupturable barrier comprises a friable or dissolvable seal. 6. The device of claim 1, wherein the device is configured for intravaginal retention in the human or animal subject. 7. The device of claim 1, further comprising at least one additional housing. 8. The device of claim 1, wherein the expansion member comprises a protrusion member effective to open the mechanical valve upon expansion of the expansion member. 9. The device of claim 1, wherein the expansion member comprises a spike member effective to puncture the rupturable barrier upon expansion of the expansion member. 10. The device of claim 1, wherein the drug comprises a lyophilized drug formulation. 11. The device of claim 1, wherein an interior surface of the first and/or second compartments comprises a hydrophobic or hydrophilic coating. 12. The device of claim 1, wherein the liquid carrier comprises water and one or more pharmaceutically acceptable excipients. 13. A method of delivering a drug comprising: deploying a drug delivery device into a human or animal subject, wherein the drug delivery device comprises a first compartment containing a drug in a dry, solid form and a second compartment containing a liquid carrier for the drug;inflating an expandable membrane to rupture a rupturable barrier or open a mechanical valve to fluidly connect the first and second compartments;mixing the liquid carrier with the drug to form a reconstituted drug solution, wherein the step of mixing the liquid carrier with the drug comprises expanding and contracting the expandable membrane; andreleasing the reconstituted drug solution from the first and/or second compartment. 14. The method of claim 13, wherein the drug comprises a lyophilized drug formulation. 15. The method of claim 13, wherein the step of releasing the reconstituted drug solution comprises inflating the expandable membrane to displace the reconstituted drug solution from the first and/or second compartments through at least one release outlet in at least one in the first and/or second compartments. 16. The method of claim 13, wherein the expansion member comprises a protrusion member effective to open the mechanical valve upon expansion of the expansion member. 17. The method of claim 13, wherein the expansion member comprises a spike member effective to puncture the rupturable barrier upon expansion of the expansion member. 18. The method of claim 13, wherein the drug delivery device is deployed into the human or animal subject intravaginally. 19. A drug delivery device comprising: a first compartment containing a drug in a dry, solid form;a second compartment containing a liquid carrier for the drug, the second compartment being fluidly connectable to the first compartment by a rupturable barrier;an expansion member; andan actuation system configured to expand and contract the expansion member to mix the liquid carrier with the drug, after the rupturable barrier is ruptured, to form a reconstituted drug solution and expel the reconstituted drug solution from the device via a release outlet. 20. The device of claim 19, wherein the rupturable barrier comprises a material configured to degrade upon being heated to a specified temperature and/or exposed to light irradiation of a specified wavelength. 21. The device of claim 19, wherein the rupturable barrier comprises a material soluble in the liquid carrier. 22. A method of administering a drug to a human or animal subject, the method comprising: providing a drug delivery device which comprises: a first compartment containing a drug in a dry, solid form,a second compartment containing a liquid carrier for the drug, andan expansion member;rupturing a rupturable barrier to place the first and second compartments in fluid communication with one another;deploying the drug delivery device in the human or animal subject; andcontrolling the expansion member to (i) expand and contract to facilitate mixing of the liquid carrier with the drug to form a reconstituted drug solution, and (ii) release the reconstituted drug solution from a release outlet of the device. 23. The method of claim 22, wherein the rupturing of the rupturable barrier is performed prior to the deployment of the drug delivery device in the human or animal subject. 24. The method of claim 23, wherein the step of rupturing the rupturable barrier comprises manually shaking the device. 25. The method of claim 24, wherein the drug comprises particles configured to puncture the rupturable barrier upon shaking. 26. The method of claim 22, wherein the rupturing of the rupturable barrier is performed after the deployment of the drug delivery device in the human or animal subject. 27. The method of claim 22, wherein the drug delivery device is deployed intravaginally in the human or animal subject.
Tafani Jean-Pierre (Paris FRX) Valter Francis (Chatenay Malabry FRX) Zeghal Slim (Paris FRX) Alexandre Jean (Paris FRX), Device for delivering a pharmacologically active principle by electrolytic pumping.
Gross Joseph (Moshav Mazor ILX) Zucker Shlomo (Yavne ILX), Device for dispensing a liquid particularly useful for delivering medicaments at a predetermined rate.
Brodman Michael L. (Great Neck NY) Kirschbaum Warren (Kemah TX) Weinberg Steven L. (League City TX), Intravaginal device and method for delivering a medicament.
Massara, Julio Eduardo; Massara, Nestor Gerardo; Dvoskin, Victor Oscar, Intravaginal devices containing progesterone for estrus synchronization and related processes.
Ausiello,Dennis; Santini, Jr.,John T.; Herman,Stephen J.; Prescott,James H.; Uhland,Scott A.; Maloney,John M.; Polito,Benjamin F., Method and device for the controlled delivery of parathyroid hormone.
Roseman Theodore J. (5313 Rugby St. Portage MI 49008) Carpenter Osmer S. (15220 Barton Lake Dr. Vicksburg MI 49097) Baker Richard W. (64485 Redmond-Bend Hwy. Bend OR 97701) Ayres James W. (2420 NW. 1, Two-member medicated device for rate-controlled administration of lipophilic pharmaceuticals.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.